When is a confirmatory randomized clinical trial needed?

被引：6

作者：

Berry, DA

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1996年 / 88卷 / 22期

关键词：

D O I：

10.1093/jnci/88.22.1606

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1606 / 1607

页数：2

共 17 条

[1]

[Anonymous], 1996, PRACTICAL MARKOV CHA

[2]

BERRY DA, 1996, BAYESIAN BIOSTATISTI, P1

[3]

Berry DA, 1996, STAT BAYESIAN PERSPE

[4]

BERRY DA, 1995, RECENT ADV CLIN TRIA, P25

[5] Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [J].

Dillman, RO ;

Herndon, J ;

Seagren, SL ;

Eaton, WL ;

Green, MR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1210-1215

[6] A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].

DILLMAN, RO ;

SEAGREN, SL ;

PROPERT, KJ ;

GUERRA, J ;

EATON, WL ;

PERRY, MC ;

CAREY, RW ;

FREI, EF ;

GREEN, MR .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :940-945

[7]

Gelman A, 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411

[8] Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor? [J].

Johnson, DH .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1175-1177

[9] RADIOTHERAPY ALONE VERSUS COMBINED CHEMOTHERAPY AND RADIOTHERAPY IN NONRESECTABLE NON-SMALL-CELL LUNG-CANCER - 1ST ANALYSIS OF A RANDOMIZED TRIAL IN 353 PATIENTS [J].

LECHEVALIER, T ;

ARRIAGADA, R ;

QUOIX, E ;

RUFFIE, P ;

MARTIN, M ;

TARAYRE, M ;

LACOMBETERRIER, MJ ;

DOUILLARD, JY ;

LAPLANCHE, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (06) :417-423

[10] INOPERABLE NON-SMALL CELL LUNG-CANCER - RADIATION WITH OR WITHOUT CHEMOTHERAPY [J].

MATTSON, K ;

HOLSTI, LR ;

HOLSTI, P ;

JAKOBSSON, M ;

KAJANTI, M ;

LIIPPO, K ;

MANTYLA, M ;

NIITAMOKORHONEN, S ;

NIKKANEN, V ;

NORDMAN, E ;

PLATIN, LH ;

PYRHONEN, S ;

ROMPPANEN, ML ;

SALMI, R ;

TAMMILEHTO, L ;

TASKINEN, PJ .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03) :477-482

← 1 2 →